Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey

Introduction: Patients with cancer and hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are underrepresented in several clinical trials testing immune checkpoint inhibitors (ICIs). Consequently, safety and efficacy of ICI therapy in this population have not been completely defined. We ai...

Full description

Bibliographic Details

Published in:	JTO Clinical and Research Reports
Main Authors:	Marco Tagliamento, MD, Jordi Remon, MD, PhD, Matteo Giaj Levra, MD, Andrea De Maria, MD, Paolo Bironzo, MD, PhD, Benjamin Besse, MD, PhD, Silvia Novello, MD, PhD, Laura Mezquita, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Subjects:	Immune checkpoint inhibitors Cancer HBV HCV Immunotherapy Viral hepatitis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666364322001709